NDATOPICALCREAM
Approved
Jun 1974
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 18h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
UTICORT is a topical corticosteroid cream containing betamethasone benzoate, a potent glucocorticoid used to treat inflammatory and pruritic dermatological conditions. It works by suppressing local immune response and reducing inflammation at the site of application. The product has been approved since 1974 and remains a foundational treatment in dermatology.
LOE Approaching
As an off-patent, legacy corticosteroid cream facing LOE, the brand team is likely small and focused on defensive positioning against generics rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
UTICORT roles are limited to defensive commercial management of a mature, generic-competitive product. Career development on this brand is constrained by lack of growth potential and minimal innovation pipeline.
Brand ManagerField Sales Representative
Worked on UTICORT at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.